Baidu
map

内分泌科指南

订阅

MedSci主页 / 所有栏目 / 内分泌科指南

2021 EANM实践指南：甲状旁腺显像

2021-04-10 欧洲核医学协会 Eur J Nucl Med Mol Imaging . 2021 Apr 10.

甲状旁腺

2021年4月，欧洲核医学协会(EANM)发布了甲状旁腺显像指南。核医学甲状旁腺显像对于鉴别原发性甲状旁腺功能亢进具有重要意义，本文主要针对甲状旁腺显像提供相关指导，以促进其最佳应用。

中文标题：

2021 EANM实践指南：甲状旁腺显像

英文标题：

The EANM practice guidelines for parathyroid imaging

发布机构：

欧洲核医学协会

发布日期：

2021-04-10

简要介绍：

2021年4月，欧洲核医学协会(EANM)发布了甲状旁腺显像指南。核医学甲状旁腺显像对于鉴别原发性甲状旁腺功能亢进具有重要意义，本文主要针对甲状旁腺显像提供相关指导，以促进其最佳应用。

 

相关资料下载：
[AttachmentFileName(sort=1, fileName=2021 EANM实践指南：甲状旁腺显像.pdf)] GetToolGuiderByIdResponse(projectId=1, id=36f311c00208e7da, title=2021 EANM实践指南：甲状旁腺显像, enTitle=The EANM practice guidelines for parathyroid imaging, guiderFrom=Eur J Nucl Med Mol Imaging . 2021 Apr 10., authorId=0, author=, summary=2021年4月，欧洲核医学协会(EANM)发布了甲状旁腺显像指南。核医学甲状旁腺显像对于鉴别原发性甲状旁腺功能亢进具有重要意义，本文主要针对甲状旁腺显像提供相关指导，以促进其最佳应用。, cover=https://img.medsci.cn/2021425/1619361928558_2020535.jpg, journalId=0, articlesId=null, associationId=401, associationName=欧洲核医学协会, associationIntro=欧洲核医学协会成立于1985年9月6日，是一个非营利性的专业医疗协会，已经拥有超过3000名会员涉及临床医生、科学家以及专业领域的相关工作人员。协会主要致力于促进整个欧洲及欧洲以外核医学的发展。, copyright=0, guiderPublishedTime=Sat Apr 10 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>2021年4月，欧洲核医学协会(EANM)发布了甲状旁腺显像指南。核医学甲状旁腺显像对于鉴别原发性甲状旁腺功能亢进具有重要意义，本文主要针对甲状旁腺显像提供相关指导，以促进其最佳应用。</p> </div> </div> </div> <div class="box_info" style="color: #373737;">&nbsp;</div>, tagList=[TagDto(tagId=886, tagName=甲状旁腺)], categoryList=[CategoryDto(categoryId=6, categoryName=内分泌科, tenant=100), CategoryDto(categoryId=40, categoryName=影像放射, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=886, guiderKeyword=甲状旁腺, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=2, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=11800, appHits=112, showAppHits=0, pcHits=891, showPcHits=11688, likes=1, shares=18, comments=5, approvalStatus=1, publishedTime=Sun Apr 25 23:33:40 CST 2021, publishedTimeString=2021-04-10, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Sun Apr 25 22:45:37 CST 2021, updatedBy=2020535, updatedName=qiushida2, updatedTime=Sat Jan 06 12:43:54 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2021 EANM实践指南：甲状旁腺显像.pdf)])
2021 EANM实践指南：甲状旁腺显像.pdf
下载请点击：
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1080669, encodeId=70ff10806691c, content=学习好资料, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0eb95611909, createdName=龙珠, createdTime=Thu Dec 16 10:26:24 CST 2021, time=2021-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069623, encodeId=38b71069623d7, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f77d4743066, createdName=feifei2511, createdTime=Fri Nov 12 13:17:40 CST 2021, time=2021-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972687, encodeId=2bc89e2687ab, content=真不错，有帮助。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210610/502e12fe56f946ba95203f901ed6519f/627525ad5c094178bf85e1d82f1b6710.jpg, createdBy=7d3d5518788, createdName=忘川秋叶, createdTime=Thu Jun 10 22:49:19 CST 2021, time=2021-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964634, encodeId=dea496463451, content=好文章！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Tue May 11 16:47:38 CST 2021, time=2021-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=963178, encodeId=361b9631e83b, content=好指南！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Thu May 06 19:48:36 CST 2021, time=2021-05-06, status=1, ipAttribution=)]
    2021-12-16 龙珠

    学习好资料

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1080669, encodeId=70ff10806691c, content=学习好资料, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0eb95611909, createdName=龙珠, createdTime=Thu Dec 16 10:26:24 CST 2021, time=2021-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069623, encodeId=38b71069623d7, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f77d4743066, createdName=feifei2511, createdTime=Fri Nov 12 13:17:40 CST 2021, time=2021-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972687, encodeId=2bc89e2687ab, content=真不错，有帮助。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210610/502e12fe56f946ba95203f901ed6519f/627525ad5c094178bf85e1d82f1b6710.jpg, createdBy=7d3d5518788, createdName=忘川秋叶, createdTime=Thu Jun 10 22:49:19 CST 2021, time=2021-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964634, encodeId=dea496463451, content=好文章！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Tue May 11 16:47:38 CST 2021, time=2021-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=963178, encodeId=361b9631e83b, content=好指南！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Thu May 06 19:48:36 CST 2021, time=2021-05-06, status=1, ipAttribution=)]
    2021-11-12 feifei2511

    谢谢分享

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1080669, encodeId=70ff10806691c, content=学习好资料, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0eb95611909, createdName=龙珠, createdTime=Thu Dec 16 10:26:24 CST 2021, time=2021-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069623, encodeId=38b71069623d7, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f77d4743066, createdName=feifei2511, createdTime=Fri Nov 12 13:17:40 CST 2021, time=2021-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972687, encodeId=2bc89e2687ab, content=真不错，有帮助。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210610/502e12fe56f946ba95203f901ed6519f/627525ad5c094178bf85e1d82f1b6710.jpg, createdBy=7d3d5518788, createdName=忘川秋叶, createdTime=Thu Jun 10 22:49:19 CST 2021, time=2021-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964634, encodeId=dea496463451, content=好文章！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Tue May 11 16:47:38 CST 2021, time=2021-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=963178, encodeId=361b9631e83b, content=好指南！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Thu May 06 19:48:36 CST 2021, time=2021-05-06, status=1, ipAttribution=)]
    2021-06-10 忘川秋叶

    真不错，有帮助。

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1080669, encodeId=70ff10806691c, content=学习好资料, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0eb95611909, createdName=龙珠, createdTime=Thu Dec 16 10:26:24 CST 2021, time=2021-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069623, encodeId=38b71069623d7, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f77d4743066, createdName=feifei2511, createdTime=Fri Nov 12 13:17:40 CST 2021, time=2021-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972687, encodeId=2bc89e2687ab, content=真不错，有帮助。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210610/502e12fe56f946ba95203f901ed6519f/627525ad5c094178bf85e1d82f1b6710.jpg, createdBy=7d3d5518788, createdName=忘川秋叶, createdTime=Thu Jun 10 22:49:19 CST 2021, time=2021-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964634, encodeId=dea496463451, content=好文章！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Tue May 11 16:47:38 CST 2021, time=2021-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=963178, encodeId=361b9631e83b, content=好指南！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Thu May 06 19:48:36 CST 2021, time=2021-05-06, status=1, ipAttribution=)]
    2021-05-11 jyzxjiangqin

    好文章！

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1080669, encodeId=70ff10806691c, content=学习好资料, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0eb95611909, createdName=龙珠, createdTime=Thu Dec 16 10:26:24 CST 2021, time=2021-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069623, encodeId=38b71069623d7, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f77d4743066, createdName=feifei2511, createdTime=Fri Nov 12 13:17:40 CST 2021, time=2021-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972687, encodeId=2bc89e2687ab, content=真不错，有帮助。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210610/502e12fe56f946ba95203f901ed6519f/627525ad5c094178bf85e1d82f1b6710.jpg, createdBy=7d3d5518788, createdName=忘川秋叶, createdTime=Thu Jun 10 22:49:19 CST 2021, time=2021-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964634, encodeId=dea496463451, content=好文章！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Tue May 11 16:47:38 CST 2021, time=2021-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=963178, encodeId=361b9631e83b, content=好指南！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Thu May 06 19:48:36 CST 2021, time=2021-05-06, status=1, ipAttribution=)]
    2021-05-06 jyzxjiangqin

    好指南！

    0

相关指南

甲状腺及甲状旁腺术中喉上神经外支保护与监测专家共识（2017版）

中国医师协会外科医师分会 甲状腺外科医师委员会 · 2017-11-30

2016 AIUM实践参数：甲状腺和甲状旁腺超声检查表现

美国医学超声学会(AIUM,American Institute of Ultrasound in Medicine) · 2016-09-01

2015 甲状腺手术中甲状旁腺保护专家共识

中国医师协会外科医师分会 · 2015-07-01

2014 原发性甲状旁腺功能亢进症诊疗指南

中华医学会骨质疏松和骨矿盐疾病分会(Chinese Medical Association) · 2014-09-20

拓展阅读

2014 原发性甲状旁腺功能亢进症诊疗指南

中华医学会骨质疏松和骨矿盐疾病分会(Chinese Medical Association) · 2014-09-20

2015 甲状腺手术中甲状旁腺保护专家共识

中国医师协会外科医师分会 · 2015-07-01

2016 AIUM实践参数：甲状腺和甲状旁腺超声检查表现

美国医学超声学会(AIUM,American Institute of Ultrasound in Medicine) · 2016-09-01

甲状腺及甲状旁腺术中喉上神经外支保护与监测专家共识（2017版）

中国医师协会外科医师分会 甲状腺外科医师委员会 · 2017-11-30

继发性甲状旁腺功能亢进热消融治疗专家共识（2021版）

中国健康促进基金会 · 2021-08-10

Baidu
map
Baidu
map
Baidu
map